Inhibition of Ehrlich's ascites cells thymidine kinase by a new class of nucleosides derivatives.
D000818:Animals; D001667:Binding, Competitive; D001966:Bromine / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology*; D003562:Cytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005260:Female; D006151:Guanosine / Q000031:analogs & derivatives / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D013936:Thymidine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors*; D013942:Thymine Nucleotides / Q000096:biosynthesis
D002250:Carbon Radioisotopes; D004273:DNA, Neoplasm; D013942:Thymine Nucleotides; D006151:Guanosine; D003562:Cytidine; D013937:Thymidine Kinase; D001966:Bromine; D013936:Thymidine